XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net Sales $ 23,771 $ 18,691 $ 61,519 $ 53,497
Cost of Sales 21,569 17,914 55,685 51,760
Gross Profit 2,202 777 5,834 1,737
Research and Product Development 494 469 939 2,963
Selling and Marketing 556 762 1,584 1,743
General and Administrative 2,889 3,254 9,434 11,845
Operating Loss (1,737) (3,708) (6,123) (14,814)
Other (Expense) Income        
Realized Gain on Settlement of Investments 220 0 220 4
Interest Expense (411) (476) (1,193) (1,497)
Interest and Other Income (Expense) - net 56 (6) 169 (10)
Total Other Expense, net (135) (482) (804) (1,503)
Net Loss $ (1,872) $ (4,190) $ (6,927) $ (16,317)
Basic Net Loss per Share (in dollars per share) $ (0.07) $ (0.23) $ (0.32) $ (1.26)
Diluted Net Loss per Share (in dollars per share) $ (0.07) $ (0.23) $ (0.32) $ (1.26)
Basic Weighted Average Shares Outstanding (in shares) [1] 27,521,088 18,463,673 21,526,978 12,902,890
Diluted Weighted Average Shares Outstanding (in shares) [1] 27,521,088 18,463,673 21,526,978 12,902,890
[1] See Note 3 for more detail related to Basic and Diluted Weighted Average Shares Outstanding